Introduction
============

Light scattering opacities of the crystalline lens, or cataracts, are a common ocular symptom of aging (\>50 years), and despite advances in their surgical treatment age-related cataracts remain a leading cause of visual impairment, accounting for \~40% of world blindness \[[@r1]\]. Rarely, cataracts may present at birth (congenital), during infancy or during childhood with an estimated prevalence of 1--13 cases/10,000 live births \[[@r2]\], and are clinically important as a cause of impaired form vision development accounting for 5%--20% of childhood blindness \[[@r3]\]. As much as 40% of early-onset cataracts may have a genetic basis \[[@r2]\], either as a recognized feature of over 50 genetic syndromes, involving other ocular defects (e.g., microphthalmia) and systemic abnormalities (e.g., galactokinase deficiency), or more often as an isolated lens phenotype with autosomal dominant inheritance (Online Mendelian Inheritance in Man; [OMIM](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM)). To date, genetic linkage studies of over 70 extended families worldwide have mapped at least 25 independent loci for clinically diverse forms of nonsyndromic cataracts on 18 human chromosomes \[[@r4]\]. The majority of underlying mutations have been identified in 10 crystallin genes (*CRYAA*, *CRYAB*, *CRYBB1*, *CRYBB2*, *CRYBB3*, *CRYBA3/A1*, *CRYBA4*, *CRYGC*, *GRYGD*, and *CRYGS*) \[[@r5]-[@r13]\] and 2 connexin genes (*GJA3*, *GJA8*) \[[@r14],[@r15]\], which encode the major "refractive" proteins and gap-junction-channel proteins of the lens, respectively. The remaining mutations have been identified in at least 10 other functionally diverse genes including those coding for transcription factors (*HSF4*, *MAF*, *PITX3*) \[[@r16]-[@r18]\], an aquaporin water channel (*MIP*) \[[@r19]\], cell-junction-like proteins (*LIM2*, *TMEM114*) \[[@r20],[@r21]\], intermediate-filament-like proteins (*BFSP2*, *BFSP1*) \[[@r22],[@r23]\], a chromatin modifying protein (*CHMP4B*) \[[@r24]\], and a solute carrier protein (*SLC16A12*) \[[@r25]\].

In addition to conventional linkage studies of inherited cataracts in extended families, sibling and twin studies indicate that genetic risk factors may account for 14%--48% of the heritability for age-related "nuclear" cataracts \[[@r26]-[@r28]\], and 24%--75% of the heritability for age-related "cortical" cataracts \[[@r29]-[@r31]\]. In contrast to inherited cataracts; however, comparatively little is known about the underlying genetic determinants predisposing to age-related cataracts \[[@r32]\]. Genes linked with inherited forms of cataracts represent likely candidate genes for age-related cataracts; however, only the "Osaka" variation (p.A198V) in the gene for autosomal recessive galactokinase-deficiency and congenital cataracts (*GALK1*) has so far been associated unambiguously with age-related cataracts, and this association appears to be limited to East Asian populations \[[@r33],[@r34]\]. Here we report for the first time that variations in the gene for Eph-receptor tyrosine kinase-type A2 (*EPHA2*) on 1p36 are associated with inherited and age-related forms of cataracts in Caucasians.

Methods
=======

Family participants
-------------------

A white American family of Western European origin (family Mu) was ascertained through ophthalmic records in the Department of Ophthalmology and Visual Sciences at Washington University School of Medicine, St. Louis, MO. Blood samples were obtained from 18 family members including 12 affected individuals, one unaffected individual, and five spouses. Leukocyte genomic DNA was purified using the Gentra Puregene Blood kit (Qiagen, Valencia, CA), and quantified by absorbance at 260nm (GeneQuant *pro*; GE Healthcare, Waukesha, WI). Ethical approval for this study was obtained from the Washington University Human Research Protection Office, and written informed consent was provided by all participants before enrollment in accordance with the tenets of the Declaration of Helsinki, and Health Insurance Portability and Accountability Act (HIPAA) regulations.

Case-control participants
-------------------------

A case-control cohort of unrelated individuals aged \>50 years form Northern Italy was ascertained from the Clinical Trial of Nutritional Supplements and Age-Related Cataract Study \[[@r35]\]. Genomic DNA was purified from blood samples as described previously \[[@r34]\], and lens status was evaluated by grading slit-lamp and retro-illumination lens photographs according to a modification of the Age-Related Eye Disease Study (AREDS) cataract grading system \[[@r36]\]. Briefly, a clear lens was defined by the following grades at the last available grading: nuclear opalescence \<3.0; cortical opacity \<5% within the five mm diameter (dia) circle at the center of the pupil, and \<15% outside this central five mm dia circle; posterior sub-capsular opacity \<1.0 % within the five mm dia central circle. A lens was defined as cataractous when at least one type of opacity was present with one or more of the following grades: nuclear opalescence ≥4.5; cortical opacity \>25% inside five mm dia central circle and/or \>25% outside five mm dia circle; posterior sub-capsular opacity \>12.5% inside five mm dia circle. Ethical approval for this study was obtained from the University of Parma and the National Eye Institute, and written informed consent was provided in accordance with the tenets of the Declaration of Helsinki.

SNP genotyping and linkage analysis
-----------------------------------

For genome-wide linkage analysis, genotyping was performed by means of the HumanLinkage-12 Genotyping Beadchip and the Infinium-II whole-genome amplification and single-base extension assay (Illumina, San Diego CA) in the Microarray Core Facility at Washington University Genome Center. Parametric multipoint linkage analysis performed with GeneHunter version 2.1r5 from the [easyLINKAGE Plus](http://genetik.charite.de/hoffmann/easyLINKAGE/) version 5.08 package \[[@r37]\]. SNP marker allele frequencies used for linkage analysis were those calculated for Caucasians by the [HapMap](http://www.hapmap.org/) project. A gene frequency of 0.001 and a penetrance of 100% were assumed for the disease locus. Computation was performed with GeneHunter in sets of 100 markers.

STR genotyping and linkage analysis
-----------------------------------

STR markers from the National Center for Biotechnology Information (NCBI) combined Généthon, Marshfield, and deCODE [genetic linkage maps](http://www.ncbi.nlm.nih.gov/genome/guide/human/) were genotyped by means of a 4200 DNA analyzer running Gene ImagIR software (Li-Cor, Lincoln, NE) as described previously \[[@r38]\]. Pedigree and haplotype data were managed using Cyrillic (v.2.1) software (FamilyGenetix Ltd., Reading, UK), and two-point LOD scores (Z) calculated using the MLINK sub-program from the [LINKAGE](http://linkage.rockefeller.edu/soft/) (5.1) package of programs \[[@r39]\]. Marker allele frequencies were assumed to be equal, and a gene frequency of 0.0001 with a penetrance of 100% were assumed for the disease locus.

Mutation analysis
-----------------

The genomic sequence for *EPHA2* was obtained from the [Ensembl](http://www.ensembl.org/index.html) human genome browser, and gene-specific M13-tailed PCR primers ([Table 1](#t1){ref-type="table"}) were selected from the NCBI re-sequencing amplicon ([RSA](http://www.ncbi.nlm.nih.gov/sites/entrez?db=probe)) probe database. Genomic DNA (2.5 ng/ul, 20 ul reactions), was amplified (35--40 cycles) in a GeneAmp 9700 thermal cycler using AmpliTaq polymerase (Applied Biosystems, Foster City, CA) and gene-specific primers (10 pmol). Resulting PCR amplicons (\~250--650 bp) were either enzyme-purified with ExoSAP-IT (USB Corporation, Cleveland, OH) or gel-purified with the QIAquick gel-extraction kit (Qiagen). Purified amplicons were direct cycle-sequenced in both directions with BigDye Terminator Ready Reaction Mix (version 3.1) containing M13 forward or reverse sequencing primers then ethanol precipitated and detected by capillary electrophoresis on a 3130xl Genetic Analyzer running Sequence Analysis (version 5.2) software (Applied Biosystems), and [Chromas](http://www.technelysium.com.au/chromas.html) (version 2.23) software (Technelysium, Tewantin, Queensland, Australia). For allele-specific PCR analysis, exon-17 was amplified with three primers (Ex17R1, Ex17SF, and T-alleleF; [Table 1](#t1){ref-type="table"}), and resulting amplicons were visualized at 302 nm following electrophoresis in 3% agarose-gels stained with GelRed (Biotium, Hayward, CA).

###### PCR primers for mutation-profiling of *EPHA2*.

  **Primer**   **Location**    **Strand**   **Sequence (5′-3′)**
  ------------ --------------- ------------ ----------------------------
  Ex1F         Intron-1        Antisense    gcgaccaagctgaaaccgcttatt
  Ex1R         5′-upstream     Sense        ggcatgaatgaacaggagtcggtt
  Ex2F         Intron-2        Antisense    cgtaccttcccacgcccatc
  Ex2R         Intron-1        Sense        ccagcctgctgtgtgccttc
  Ex3F1        Exon-3          Antisense    ACGGCATGGTCCACACAGGT
  Ex3R1        Intron-2        Sense        ccaggcacctgcccacacta
  Ex3F2        Intron-3        Antisense    aaggaaactgatgtctgggaagga
  Ex3R2        Exon-3          Sense        CCAGAAGCGCCTGTTCACCA
  Ex4F         Exon-5          Antisense    CAGACTCGGGCCAGCACTGT
  Ex4R         Intron-3        Sense        ttcctgggtgcccggtacat
  Ex5F         Intron-5        Antisense    gacactgtgcctttaaccacttgctc
  Ex5R         Exon-4          Sense        GCTTCTTCCGGGCACCTCAG
  Ex6F         Intron-6        Antisense    ctctgctgtgctgccttggg
  Ex6R         Intron-5        Sense        tgcctgctcgtaggcagctt
  Ex7F         Intron-7        Antisense    ccgccggtgaccgagaaag
  Ex7R         Intron-6        Sense        ggcgtccttggaagaggcag
  Ex8F         Intron-8        Antisense    gattcctgcctgcgtgtcca
  Ex8R         Intron-7        Sense        tggagccttcccaagtgcaa
  Ex9/10F      Intron-10       Antisense    accaccgctgcctcctca
  Ex9/10R      Intron-8        Sense        tgggccgcattctgagcac
  Ex10/11F     Intron-11       Antisense    cctctccacccagtgtgggc
  Ex10/11R     Intron-9        Sense        cccacagcctggtccaagtc
  Ex12F        Exon-13         Antisense    TGGTGGTGTAGGTGGCCTCG
  Ex12R        Intron-11       Sense        tacctctgcccactcctccg
  Ex13F        Exon-14         Antisense    CGTCGCTGGCAGAGGTGAAC
  Ex13R        Exon-12         Sense        CCCTGGACAAGTTCCTTCGGg
  Ex14F        Intron-14       Antisense    aactgtcctctgcccagccc
  Ex14R        Exon-13         Sense        CGAGGCCACCTACACCACCA
  Ex15F        Intron-15       Antisense    ctgggccatcgtgtccagtc
  Ex15R        Intron-14       Sense        gggcagctctgaaggttggg
  Ex16F        Intron-16       Antisense    tggcggagttctgcccttct
  Ex16R        Intron-15       Sense        gactgggcttccctgttgcc
  Ex17F1       Exon-17         Antisense    agggaccgctttgggtctca
  Ex17R1       Intron-16       Sense        ctctccctctctccctcccg
  Ex17F2       Exon-17         Antisense    ccctgccacacacacacattc
  Ex17R2       Exon-17         Sense        agtggcctccctgctgtgc
  Ex17F3       3′-downstream   Antisense    gctcccagggttaagtgacgtg
  Ex17R3       Exon-17         Sense        gcagactgtgaacttgactgggtga
  T-alleleF    Exon-17         Antisense    GCCGGGCAGCCGCACCCA
  Ex17SF       Exon-17         Antisense    ggaggccactctgtttcttcaagt

Gene specific primers used for amplification and sequencing of exons 1--17 and flanking intron regions of *EPHA2* on chromosome 1p. Coding and noncoding sequence are shown in uppercase and lowercase, respectively. Antisense primers were 5′-tailed with the M13-forward universal sequence (5′-tgtaaaacgacggccagt), and sense primers were 5′-tailed with the M13-reverse universal sequence (5′-caggaaacagctatgacc). The allele-specific primer (T-alleleF) was used to detect the heterozygous c.2842G\>T transversion in exon-17 as shown in [Figure 3](#f3){ref-type="fig"}.

SNP association analysis
------------------------

For association studies, tagging SNPs covering the *EPHA2* region were selected from the [HapMap](http://www.hapmap.org/) database using the [Haploview](http://www.broad.mit.edu/mpg/haploview/download.php) program \[[@r40]\]. SNPs were genotyped by a combination of TaqMan melt-curve assays "on-demand" (Applied Biosystems), SNaPshot single-base extension assays (Applied Biosystems), and direct BigDye Terminator cycle-sequencing (Applied Biosystems). TaqMan assays were run on a 7900 HT real-time PCR system (Applied Biosystems). SNaPshot assays and di-deoxy cycle-sequencing were performed on a 3130 DNA analyzer (Applied Biosystems), and sequence analysis was performed with the Mutation Surveyor program (Soft Genetics, State College, PA).

Statistical analyses
--------------------

Tagging SNPs and haplotype blocks were identified using the [Haploview](http://www.broad.mit.edu/mpg/haploview/download.php) program \[[@r40]\], and association statistics including χ^2^, trend p values, and odds ratios were calculated using the Exemplar program version 4.04 (Sapio Sciences, York, PA). Hardy--Weinberg equilibrium was assessed using a χ^2^ test implemented in the Exemplar program.

Results
=======

Linkage studies
---------------

We investigated a four generation white family from the United States (family Mu) segregating "posterior polar" cataracts in the absence of systemic abnormalities ([Figure 1A](#f1){ref-type="fig"}). Autosomal dominant inheritance was supported by father-to-son transmission in the absence of gender bias or skipping of generations. Ophthalmic records indicated that the cataracts usually presented in both eyes as disc-shaped posterior sub-capsular opacities with evidence of posterior lenticonus ([Figure 1B](#f1){ref-type="fig"}). In three affected individuals, opacification progressed to affect the central (nucleus) and anterior polar regions of the lens (IV:5, IV:6, IV:7; [Figure 1A](#f1){ref-type="fig"}). In addition to cataracts, one affected individual had monocular amblyopia (III:8), and two others developed strabismus requiring corrective surgery (IV:1, IV:5). The age-at-diagnosis varied from birth to15 years, and the age-at-surgery ranged from 0 to 44 years. Post-surgical corrected visual acuity varied from 20/20 to 20/70 in the better eye.

![Autosomal dominant posterior polar cataracts in a four generation white American pedigree (family Mu). **A:** Pedigree and haplotype analysis showing segregation of seven STR markers on chromosome 1p listed in descending order from the telomere. Squares and circles denote males and females, respectively. Filled symbols and bars denote affected status and haplotypes, respectively. **B**: Slit-lamp image of left lens from affected female IV:6 (age 12 years) showing posterior sub-capsular opacity. **C**: Ideogram of chromosome 1p36, comparing the cytogenetic and physical locations of STR markers defining the posterior polar cataract locus in this study (red) with those defining 3 other loci (black) for autosomal dominant cataracts (CCV, CTPP1 and Total) \[[@r45]-[@r47]\], and a locus (blue) for age-related cortical cataracts \[[@r44]\]. M, mega-base pairs.](mv-v14-2042-f1){#f1}

For genome-wide linkage analysis, the 12 affected individuals in family Mu were genotyped by means of the HumanLinkage-12 Panel (Illumina), which comprises 6090 SNP markers uniformly spaced at an average genetic distance of 0.58 cM. Parametric multipoint analysis performed with [GeneHunter](http://www.broad.mit.edu/ftp/distribution/software/genehunter) (v2.1r5) detected significant evidence of linkage ([Figure 2](#f2){ref-type="fig"}) on chromosome 1p (pLOD 3.3), and weak evidence of linkage on chromosome 17p (pLOD 1.8). Haplotype reconstruction further identified a common disease interval on 1p36 ([rs707455](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=707455)-\[\~10Mb\]-[rs477558](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=477558)) that cosegregated with the disease in all 12 affected individuals ([Table 2](#t2){ref-type="table"}).

![Parametric multipoint LOD scores (pLOD) for linkage between the posterior polar cataract phenotype in family Mu and SNP markers across the 22 autosomes.](mv-v14-2042-f2){#f2}

###### SNP disease haplotype for the cataract-linked interval on chromosome 1p.

    **SNP**                                                                    **Disease allele**     **Distance from 1-ptel**   
  -------------------------------------------------------------------------- ---------------------- ---------------------------- ---------
  [rs707455](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=707455)   \*       C                      7.75                         13.68
  [rs8627](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=8627)                A                      8.34                         14.21
  [rs1473420](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1473420)          A                      8.54                         14.48
  [rs916380](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=916380)            A                      9.26                         15.43
  [rs630075](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=630075)            T                      9.29                         15.47
  [rs6677649](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=6677649)          A                      9.67                         16.64
  [rs2119508](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2119508)          G                      9.78                         16.66
  [rs2379107](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2379107)          A                      9.83                         16.67
  [rs7528979](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7528979)          C                      10.02                        16.70
  [rs6541085](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=6541085)          A                      10.21                        16.73
  [rs912962](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=912962)            T                      10.27                        16.74
  [rs649101](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=649101)            T                      10.41                        16.77
  [rs2506887](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2506887)          A                      10.51                        16.78
  [rs481453](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=481453)            T                      10.60                        16.99
  [rs488834](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=488834)            T                      10.69                        17.33
  [rs7555879](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7555879)          G                      10.81                        17.76
  [rs2273348](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2273348)          C                      11.00                        18.43
  [rs4846012](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=4846012)          G                      11.48                        20.07
  [rs2817594](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2817594)          A                      11.54                        20.24
  [rs3818157](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3818157)          G                      11.95                        21.26
  [rs235256](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=235256)            C                      12.22                        21.31
  [rs761162](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=761162)            A                      14.24                        24.73
  [rs1416633](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1416633)          C                      14.36                        24.96
  [rs7531416](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7531416)          A                      14.62                        25.58
  [rs3927648](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3927648)          A                      14.74                        25.86
  [rs1883661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1883661)          A                      14.88                        26.20
  [rs4357518](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=4357518)          A                      14.95                        26.46
  [rs3845596](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3845596)          T                      15.06                        26.91
  [rs7515649](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7515649)          C                      15.31                        27.49
  [rs488595](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=488595)            G                      15.56                        27.95
  [rs1007150](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1007150)          T                      16.49                        29.61
  [rs761423](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=761423)            G                      17.17                        30.83
  [rs1005753](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1005753)          A                      17.32                        31.08
  [rs3766306](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3766306)          T                      17.84                        32.02
  [rs1578215](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1578215)          G                      17.99                        32.31
  [rs477558](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=477558)   \*\*     G                      18.09                        32.53

The disease associated allele is shown for each SNP in the cataract interval, which spans \~10 megabases (Mb) or \~19 centi-Morgans (cM). The asterisk denotes critical recombinant individual III:8 in family Mu ([Figure 1A](#f1){ref-type="fig"}) with genotype T/T at [rs707455](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=707455). The double asterisk denotes critical recombinant individual IV:6 ([Figure 1A](#f1){ref-type="fig"}) with genotype A/A at [rs477558](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=477558).

To validate the authentic SNP interval from the genome-wide linkage scan, all 18 family members were genotyped with STR markers. We first excluded false-positive linkage to the SNP interval on 17p using markers D17S1852 (Z=-3.75, θ=0) and D17S921 (Z=-∞, θ=0, data not shown). Subsequently, we obtained confirmatory evidence of linkage on 1p ([Table 3](#t3){ref-type="table"}) for markers D1S2672 (Z=3.56, θ=0), D1S2697 (Z=2.92, θ=0), and D1S436 (Z=2.84, θ=0). Haplotype analysis detected four recombinant individuals within the Mu pedigree ([Figure 1A](#f1){ref-type="fig"}). An affected female (III:8), her affected son (IV:5), and two affected daughters (IV:6, IV:7) were obligate recombinants distal to the centromere at D1S214. In addition, one of the affected daughters (IV:6) was recombinant proximal to the centromere at D1S2644. However, no further recombinant individuals were detected at five other intervening STR markers, consistent with the cataract locus residing in the physical interval, D1S214-(\~12 Mb)-D1S2644 ([Figure 1C](#f1){ref-type="fig"}), which was coincident with the SNP interval on 1p.

###### Two-Point LOD scores (Z) for linkage between the cataract locus in family Mu and markers on chromosome 1p.

  **Marker**                                                          **Distance from 1p-tel**   **Z at θ=**    **Z~Max~**   **θ~Max~**                                          
  ------------------------------------------------------------------- -------------------------- -------------- ------------ ------------ ------- ------- ------- ------- ------ ------
  D1S2795                                                             14.20                      5.50           -0.47        2.24         2.24    1.88    1.33    0.66    2.27   0.07
  D1S214                                                              16.40                      6.88           -0.44        2.27         2.27    1.91    1.35    0.67    2.30   0.08
  [rs707455](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=707455)                              7.75           -3.70        -0.64        -0.37   -0.15   -0.05   -0.01   0.00   0.05
  D1S2736                                                             22.90                      10.54          2.62         2.38         2.14    1.62    1.05    0.47    2.62   0.00
  D1S489                                                              32.30                      11.97          1.54         1.41         1.28    1.01    0.71    0.38    1.54   0.00
  D1S507                                                              36.20                      14.90          2.61         2.38         2.13    1.60    1.03    0.45    2.61   0.00
  D1S2672                                                             36.20                      15.15          3.56         3.25         2.93    2.25    1.51    0.71    3.56   0.00
  D1S436                                                              39.90                      15.74          2.84         2.59         2.32    1.76    1.15    0.52    2.84   0.00
  D1S2697                                                             39.90                      16.29          2.92         2.66         2.39    1.82    1.20    0.55    2.92   0.00
  EPHA2 c.2842G\>T                                                                               16.32--16.36   3.61         3.30         2.98    2.28    1.52    0.72    3.61   0.00
  D1S1592                                                                                        17.94          1.26         1.16         1.05    0.83    0.59    0.32    1.26   0.00
  [rs477558](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=477558)                              18.09          -4.43        -0.57        -0.33   -0.14   -0.06   -0.02   0.00   0.50
  D1S2644                                                             46.20                      18.90          -∞           -0.38        -0.15   0.03    0.07    0.06    0.07   0.32

Z values for markers on 1p listed in genetic and physical distances measured in cM and Mb, respectively, from the telomere (1p-tel). The maximum Z values (Zmax) occurred at marker D1S2672, and at the c.2842G\>T transversion in exon-17 of *EPHA2*. θ=recombination fraction.

Mutation analysis
-----------------

The SNP and STR intervals contained 211 and 219 positional-candidate genes, respectively, none of which were obvious functional candidates for cataracts in family Mu (NCBI [Map Viewer](http://www.ncbi.nlm.nih.gov/mapview/)). We prioritized genes for mutation analysis of exons and intron boundaries (splice-sites) primarily based on evidence of expression or function in the eye, from the NCBI [UniGene](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=unigene) expressed sequence tag (EST) database, and the [NEIBank](http://neibank.nei.nih.gov/index.shtml) bioinformatics resource for vision research \[[@r41]\]. Re-sequencing analysis of individuals II:1, III:8, and III:9 from the Mu pedigree ([Figure 1A](#f1){ref-type="fig"}) excluded the presence of coding or splice-site mutations in several genes including *ENO1* (GeneID: [2023](http://www.ncbi.nlm.gov/sites/entrez?db=gene&cmd=search&term=2023)), which according to [NEIBank](http://neibank.nei.nih.gov/index.shtml) is abundantly expressed in the human lens. However, re-sequencing of a 17-exon gene symbolized *EPHA2* (GeneID: [1969](http://www.ncbi.nlm.gov/sites/entrez?db=gene&cmd=search&term=1969)), which is also expressed in human lens ([NEIBank](http://neibank.nei.nih.gov/index.shtml)), identified a heterozygous c.2842G\>T transversion in exon-17 that was not present in wild type ([Figure 3B](#f3){ref-type="fig"}). This single nucleotide change did not result in the gain or loss of a convenient restriction site, therefore we designed allele-specific (G/T) PCR analysis to confirm that the mutant "T" allele cosegregated with affected but not unaffected members of family Mu ([Figure 3C](#f3){ref-type="fig"}). Furthermore, when we tested the c.2842G\>T transversion as a bi-allelic marker, with a notional allelic frequency of 1%, in a two-point LOD score analysis of the cataract locus ([Table 3](#t3){ref-type="table"}) we obtained further compelling evidence of linkage (Z=3.61, θ=0). In addition, we confirmed that the c.2842G\>T transversion was not listed in the NCBI SNP database ([dbSNP](http://www.ncbi.nlm.nih.gov/projects/SNP/)), and excluded it as a SNP in a panel of 192 normal unrelated individuals (i.e., 384 chromosomes) using the allele-specific PCR analysis described in [Figure 3C](#f3){ref-type="fig"} (data not shown). While it is possible that an undetected mutation lay elsewhere within the disease-haplotype interval, our genotype data strongly suggested that the c.2842G\>T transversion in exon 17 of *EPHA2* represented a causative mutation rather than a benign SNP in linkage disequilibrium with the cataract phenotype.

![Mutation analysis of *EPHA2* in family Mu. **A**: Sequence trace of the wild type allele showing translation of glycine (G) at codon 948 (GGG). **B**: Sequence trace of the mutant allele showing the heterozygous c.2842G\>T transversion (denoted K by the International Union of Pure and Applied Chemistry \[IUPAC\] code) that is predicted to result in the missense substitution of tryptophan (TGG) for glycine at codon 948 (p.G948W). **C**: Allele-specific PCR analysis using the 3 primers ([Table 1](#t1){ref-type="table"}) indicated by arrows in the schematic diagram; exon-17 was amplified as above with the sense (anchor) primer located in intron 16 (Ex17R1), the anti-sense primer located in the 3′-untranslated region (Ex17SF), and the nested mutant primer specific for the T-allele in codon 948 (T-alleleF). Note that only affected members of family Mu are heterozygous for the mutant T-allele (80 bp).](mv-v14-2042-f3){#f3}

The c.2842G\>T transversion identified above occurred at the first base of codon 948 ([G]{.ul}GG \>[T]{.ul}GG), and was predicted to result in the missense substitution of glycine to tryptophan (p.G948W) at the level of translation ([Figure 4](#f4){ref-type="fig"}), placing it in the cytoplasmic sterile-α-motif (SAM) domain of EPHA2 \[[@r42],[@r43]\]. Cross-species alignment of the amino acid sequences for EPHA2 present in the [Entrez protein](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Protein) database, performed by means of [ClustalW](http://www.ebi.ac.uk/clustalw/) multiple sequence alignment, revealed that p.G948 is evolutionarily conserved within the bony vertebrates ([Figure 4B](#f4){ref-type="fig"}). Moreover, the predicted p.G948W substitution represented a nonconservative amino acid change, with the small neutral, polar side-group (-H) of glycine replaced by the much larger neutral, hydrophobic side-group (-CH~2~-C~8~ H~4~NH) of tryptophan. Position specific score matrix analysis ([PSSM Viewer](http://www.ncbi.nlm.nih.gov/Class/Structure/pssm/pssm_viewer.cgi)) revealed a marked decline in value from +6 to −6 ([Table 4](#t4){ref-type="table"}) confirming that the predicted p.G948W substitution occurred less frequently than expected in proteins with the conserved SAM domain (Conserved Domain Database \[[CDD](http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml)\] pfam00536) further raising the likelihood of functional consequences.

![Schematic diagram showing gene structure and protein domains of *EPHA2*. **A**: Exon-intron organization, mutation profile and protein domains. Intron sizes are shown in base-pairs (bp), and codons are numbered below each exon (boxes). The approximate locations of protein domains are indicated. SP, signal-peptide; Eph-lbd, Eph-receptor ligand binding domain; EGF-like, epithelial growth factor-like region; Fn-3, fibronectin type-III domain; Tm-1, transmembrane domain type-1; Pkinase-Tyr, protein tyrosine kinase domain; SAM, sterile-α-motif. The predicted p.G948W missense mutation identified in family Mu is proposed to reside in the cytoplasmic SAM domain. **B**: Amino acid sequence alignment of the SAM domain from human EPHA2 and orthologs from other species, showing conservation of p.G948. Divergent amino-acids residues are shaded. The SAM domain comprises an NH~2~-terminal extended strand (dots), 5 α-helices (H1--5, over-lined), and a core sub-unit (bolded). The proposed p.G948W substitution likely resides between H-4 and H-5.](mv-v14-2042-f4){#f4}

###### Position specific score matrix (PSSM) analysis of the predicted p.G948W substitution in EPHA2.

  **Codon**
  -----------

Differences in the physico-chemical properties of glycine and tryptophan are consistent with a non-conservative substitution. The negative PSSM value indicates that tryptophan substitutes for glycine at position 948 less frequently than expected among proteins containing the conserved SAM domain.

Association studies
-------------------

*EPHA2* resides within a large interval (D1S468-\[\~25.5 Mb\]-D1S1622) on chromosome 1p ([Figure 1C](#f1){ref-type="fig"}) that was previously linked with age-related cortical cataracts in families and sib-pairs from the Beaver Dam Eye Study \[[@r44]\]. To investigate the possibility that *EPHA2* was associated with age-related cataracts, we performed candidate-gene SNP allele association studies in a case-control cohort from Northern Italy \[[@r34],[@r35]\]. This clinically well defined cohort was of similar European ancestry to that of family Mu, and comprised 126 unrelated individuals with nuclear cataracts, 119 with cortical cataracts, and 104 unrelated controls with clear lenses ([Table 5](#t5){ref-type="table"}). Of the cases, 28 had both nuclear and cortical cataracts, three had nuclear and posterior sub-capsular cataracts, 10 had cortical and posterior sub-capsular cataracts, and four had nuclear, cortical, and posterior sub-capsular cataracts.

###### Age, gender and lens status of the Italian case-control cohort of age-related cataracts.

  **Lens status**          **Age range**   **Mean age (±2 SD)**   **Males (%)**   **Females (%)**   **Total**
  ------------------------ --------------- ---------------------- --------------- ----------------- -----------
  Any cortical cataracts   57--86          75.6 (63.7--87.5)      57 (48)         62 (52)           119
  Any nuclear cataracts    50--86          75.8 (63.0--88.6)      75 (60)         51 (40)           126
  Any cataracts            50--86          75.7 (63.2--88.2)      114 (54)        99 (46)           213
  Clear lenses             61--86          74.5 (64.6--84.5)      61 (59)         43 (41)           104

The cohort of unrelated individuals comprised a total of 213 age-related cataract cases and 104 clear lens controls, matched for age and gender. Cases with both nuclear and cortical cataracts (32) were counted in both the any cortical and any nuclear groups. Cases with any posterior sub-capsular cataracts (17) were not analyzed separately due to statistically insufficient numbers.

In an initial screen, tagging SNPs covering the *EPHA2* region were genotyped using 100 samples each from individuals with any nuclear, any cortical and no age-related cataracts. Markers yielding p values \<0.05 were further analyzed using the entire complement of samples ([Appendix 1](http://www.molvis.org/molvis/v14/a241/app-1.pdf), [Figure 5](#f5){ref-type="fig"}). All markers were in Hardy--Weinberg equilibrium (HWE, p\>0.05) for all sample groups tested. The highest levels of association occurred with [rs7543472](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7543472) (allelic p\<0.038 for cortical cataracts, and allelic p\<0.021 for any age related cataracts) and [rs11260867](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11260867) (allelic p\<0.020 for cortical cataracts), which lie just distal (3′) to *EPHA2* ([Figure 5](#f5){ref-type="fig"}). However, there was no significant association with nuclear cataracts, although results with [rs7543472](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7543472) were suggestive (allelic p\<0.071, [Appendix 1](http://www.molvis.org/molvis/v14/a241/app-1.pdf)). These findings were true whether the analysis was for pure cortical cataracts, any cortical cataracts, pure nuclear cataracts, or any nuclear cataracts. Since association was seen between SNPs in the *EPHA2* region and cortical cataracts and suggestive results were obtained with nuclear cataracts, the analysis was extended to include any age-related cataracts with subsequent increased association in SNPs from the peak region to p\<0.021 with the T-allele of [rs7543472](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7543472), although the G-allele of [rs11260867](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11260867) actually lost significance slightly (p=0.076). Results for SNPs outside this region changed only minimally. Because the SNPs showing the greatest association lay over or just beyond exon 17, this region was sequenced in all samples. The only variation occurring with a frequency greater than 0.05 was [rs3754334](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3754334), a synonymous p.I958I (C3011T) variant. This variant had minor allele frequencies of \~34% in cataract cases and 28% in controls, and was thus analyzed further, although the association was not as strong as with the two distal (3′) SNPs ([rs7543472](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7543472) or [rs11260867](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11260867)) and no significant allelic p values were obtained. Allelic odds ratios ranged from 1.5 to 1.7, for [rs7543472](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7543472), and 1.2--1.9 for [rs11260867](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11260867), but were not significant for [rs3754334](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3754334). The p values obtained were not corrected for multiple testing as these SNPs were tested, a priori, for association with age-related cataracts on the basis of their close proximity to a gene linked with inherited cataracts that also maps within a known linkage region for age-related cataracts, rather than as part of a genome-wide scan.

![Graphical presentation of association between SNPs in the *EPHA2* region of chromosome 1p with age-related cataracts in the Italian case-control cohort. The upper panel shows a plot of -log p-values (y-axis) from association analyses of 21 SNPs across the *EPHA2* region. Blue diamonds denote -log p values for pure cortical cataracts; red squares, any cortical cataracts; green triangles, pure nuclear cataracts; purple x, any nuclear cataracts; and light blue asterisks, any cataracts. The x-axis shows the relative physical location of each SNP measured in mega-base-pairs. The lower panel shows a pairwise linkage disequilibrium (D´) [Haploview](http://www.broad.mit.edu/mpg/haploview/download.php) plot for SNPs in the *EPHA2* region. The strength of linkage disequilibrium (LD) is color-coded; red indicates strong LD with SNPs showing high correlation, and blue indicates low LD and high recombination. The relative positions of *EPHA2* and the adjacent *FAM131C* are indicated with haplotype blocks for the European population (CEU) from the [HapMap](http://www.hapmap.org/) project (SNPbrowser, Applied Biosystems).](mv-v14-2042-f5){#f5}

Trend p values were very similar to allelic p values for all SNPs, but the specific genotypes show greater levels of association for all SNPs showing significant association ([Appendix 1](http://www.molvis.org/molvis/v14/a241/app-1.pdf)). The most significant was p\<0.007 for cortical cataracts with [rs11260867](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11260867) (GG genotype), p\<0.012 for cortical cataracts and p\<0.01 for any cataracts with [rs7543472](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7543472) (TT genotype), and p\<0.019 for cortical cataracts and p\<0.028 for any cataracts with [rs3754334](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3754334) (TT genotype). In addition, association of nuclear cataracts with the TT genotype of [rs7543472](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7543472) is marginally significant at p\<0.042 and suggestive with the TT genotype of [rs3754334](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3754334) at p\<0.06. Genotypic odds ratios show the greatest risk increase in individuals homozygous for the risk alleles, ranging from 1.9 to 2.1 for [rs7543472](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7543472), 1.5--2.3 for [rs11260867](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11260867), and 2.7--3.3 for [rs3754334](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3754334), depending on the type of age-related cataracts being considered ([Appendix 1](http://www.molvis.org/molvis/v14/a241/app-1.pdf)).

The association of a potential risk haplotype for these three SNPs was examined; however, the association level was found to be essentially that of the least associated SNP. This result was consistent with the observation that all but 4 affected individuals with the homozygous TT genotype for [rs3754334](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3754334) also had a homozygous TT genotype for [rs7543472](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7543472), and all but one had a homozygous GG genotype for [rs11260867](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11260867). Similarly, of affected individuals with a homozygous TT genotype for [rs7543472](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7543472) only a single individual did not have a homozygous GG genotype for [rs11260867](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11260867). However, because the genotype frequency of TT for [rs3754334](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3754334) was only \~15% it did not show strong linkage disequilibrium with [rs11260867](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11260867) (D´=0.018) or [rs7543472](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7543472) (D´=0.022). In contrast, [rs11260867](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11260867) and [rs7543472](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7543472), for which the risk genotypes have frequencies of \~80% and \~73% respectively, showed strong linkage disequilibrium (D´=0.896).

Discussion
==========

In this study, we have mapped an interval on human chromosome 1p36 for autosomal dominant posterior polar cataracts, and identified an underlying missense mutation (p.G948W) in the gene coding for EPHA2, which has not previously been associated with eye disease. Our disease interval maps in close proximity to autosomal dominant loci for the Volkman congenital cataract (CCV) in a Danish family \[[@r45]\], posterior polar cataract (CCTP1) in a British family \[[@r46]\], and total congenital cataract in a Tasmanian family \[[@r47]\], raising the possibility of allelism ([Figure 1C](#f1){ref-type="fig"}). In addition, *EPHA2* resides within a large interval (D1S468-\[\~25.5 Mb\]-D1S1622) on chromosome 1p ([Figure 1C](#f1){ref-type="fig"}) that was previously linked with age-related cortical cataracts in families and sib-pairs from Beaver Dam, Wisconsin \[[@r44]\]. Here, we further demonstrate that variations in the *EPHA2* region are associated with age-related cortical cataracts (p=0.007), and age-related cataracts overall (p=0.01) in an Italian population.

*EPHA2* encodes a 976 amino acid, type-1 transmembrane protein (\~108 kDa) with extracellular NH~2~-terminal and cytoplasmic COOH-terminal halves ([Figure 4B](#f4){ref-type="fig"}) \[[@r42]\]. The extracellular region comprises a conserved Eph-ligand binding domain followed by a cysteine-rich EGF-like domain, and two fibronectin type-III repeats, whereas, the cytoplasmic region contains a conserved tyrosine kinase domain, and a sterile-α-motif (SAM) domain \[[@r42]\]. The proposed p.G948W missense substitution, cosegregating with cataracts in family Mu, was predicted to reside in the cytoplasmic SAM domain of EPHA2. The evolutionarily conserved \~70 amino acid SAM domain has a compact helical structure that is believed to facilitate protein--protein interactions \[[@r43]\], raising the possibility that the predicted p.G948W substitution may interfere with Eph-receptor oligomerization and clustering into higher-order complexes essential for physiologic signaling \[[@r42]\].

In contrast to the heterozygous genotype and dominant phenotype linked with the p.G948W mutation in *EPHA2*, the SNPs in the *EPHA2* region most associated with age-related cataracts displayed the highest odds ratios when homozygous for the risk allele, consistent with recessive effects. Furthermore, the p.G948W mutation was linked with posterior polar cataracts, which most resemble age-related posterior sub-capsular cataracts, whereas, *EPHA2* SNPs were associated with much more prevalent forms of age-related cataracts, in decreasing order of significance; cortical opacities \> any opacities \> nuclear opacities. While it is problematic to compare inherited and age-related forms of cataracts, it is noteworthy that some of the affected members of family Mu also developed nuclear and anterior polar opacities. These observations raise the possibility that *EPHA2* variants may contribute to a common pathogenic mechanism resulting in different cataract phenotypes. The existence of any such mechanism remains to be determined; however, it is interesting that the two SNPs in the *EPHA2* region most associated with age-related cataracts ([rs7543472](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7543472) and [rs11260867](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11260867)) lie outside the coding region near the 3′-end of the gene, which has been shown to harbor highly conserved translational control sequences that are believed to facilitate an RNA-based post-transcriptional mechanism for localized regulation of gene expression within cells \[[@r48],[@r49]\].

EPHA2 is a member of the largest sub-family of receptor tyrosine kinases, which are divided into 2 classes; the A-subclass comprising 10 receptor genes (*EPHA1--10*) and the B-sub-class with 6 receptor genes (*EPHB1--6*) \[[@r50],[@r51]\]. [Eph]{.ul} [r]{.ul}eceptors [in]{.ul}teract with their cognate membrane-anchored ligands, referred to as ephrins (*EFNA1--6*, *EFNB1--3*), at cell-cell contact sites to activate bidirectional signaling pathways effecting diverse physiologic processes including; cell adhesion, repulsion, morphology, and migration \[[@r50],[@r51]\]. Intriguingly, EPHA2 has been implicated in tumor angiogenesis and neurite outgrowth; however, little is known about its role in the development and homeostasis of the avascular, noninnervated lens. Recently, however, it has been reported that mice lacking ephrin-A5, a ligand of Epha2, develop cataracts as a result of impaired lens fiber cell adhesion \[[@r52]\]. Further characterization of Eph-ephrin signaling pathways in the lens should provide insight into the pathogenetic mechanisms linking EPHA2 dysfunction with cataractogenesis.

In conclusion, our data have associated *EPHA2* with both inherited and age-related cataracts, and suggest that dysfunction of a member of the EphA-receptor tyrosine kinase sub-family triggers loss of lens transparency.

Calculated significance values (p=\< 0.05) show most association between rs11260867 and any cortical cataracts, and between rs7543472 and any cataracts. To access the data, click or select the words "[Appendix 1](http://www.molvis.org/molvis/v14/a241/app-1.pdf)." This will initiate the download of a compressed (pdf) archive that contains the file.
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